ATMOS Inc, Allentown, Pennsylvania, has entered the negative pressure wound therapy (NPWT) market with the S041 Wound Pump, which is the first of several new innovative suction pump products that will be available to the global marketplace in the coming months. The S041's approach to wound management and healing uses NPWT, which has been shown to improve the healing process and greatly decrease the risk of infection and amputation and length of hospital stay, and has the potential to save billions of dollars in annual healthcare costs, according to the manufacturer. The S041 Wound Pump supports quick mobilization of the patient and fewer dressing changes and is a cost-effective means to treating wounds. At the push of a button, the vacuum adjusts quickly and precisely to set levels because of a novel sensor design. The technology of the S041 Wound Pump allows an almost noiseless operation and an innovative intermittent mode that allows settings up to 5 minutes on or off. The device also has a patient safety lock and an acoustic/visual alarm.
[black up pointing small triangle] Information:http://www.atmosmed.us
Arobella Medical, LLC, Minnetonka, Minnesota, announced European CE Mark approval of its Qoustic Wound Therapy System medical device for ultrasound-aided wound care. The wound therapy system uses a unique, dome-shaped curette tip to apply low-frequency, cavitational ultrasound to wounds. The combination of physical design and ultrasonic energy gently removes dead and diseased tissue cells, kills harmful bacteria and biofilm, and leaves healthy and prehealing granulation tissue intact. The device is cleared by the US Food and Drug Administration and is already on sale in the United States.
[black up pointing small triangle] Information:http://www.arobella.com
Eloquest Healthcare, Inc, Ferndale, Michigan, has partnered with Onset Therapeutics, LLC, Cumberland, Rhode Island, to market Exactacain and Optase to the acute-care market. Eloquest Healthcare is a 1-year-old dermatology specialty company that focuses on improving dermal outcomes for the acute-care market. Onset Therapeutics is a specialty pharmaceutical company focusing on the development and commercialization of novel, patent-protected topical products for the treatment of skin disorders. Optase is a prescription product formulated in a patent-pending gel delivery system for topical application, which promotes healing in the treatment of decubitus ulcers, varicose ulcers, and dehiscent wounds. Exactacain will be targeted primarily to the acute-care market, including critical care units, emergency departments, anesthesia, endoscopy departments, and hospital pharmacies.
[black up pointing small triangle] Information:http://www.eloquesthealthcare.com
Kinetic Concepts, Inc, San Antonio, Texas, has entered an exclusive partnership with Carroll Hospital Group, Inc, London, Ontario, Canada, designed to improve the overall safety of patients. The partnership combines Carroll Hospital Group, Inc's newest medical-surgical bed, Spirit Select, with KCI's broad mattress replacement portfolio, which includes multiple products that provide skin management for pressure ulcers. This combination provides hospitals with the flexibility needed to safely manage and transport patients, increase patient mobility, and, most importantly, reduce "never events," such as hospital-acquired pressure ulcers and patient falls. For example, KCI's novel therapies, such as the AtmosAir 9000 system, designed with self-adjusting pressure technology, can be combined with the flexible Spirit Select bed. Manufactured exclusively by Carroll Hospital Group, Inc, the Spirit Select low bed is the newest product offered by KCI's Therapeutic Support Systems division.
[black up pointing small triangle] Information:http://www.kci1.com